Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Illumina
MedTech
JPM25: Regeneron, Illumina back Truveta to sequence 10M genomes
Illumina and Regeneron are taking stakes in health data company Truveta to help fund research that may dwarf previous DNA sequencing projects.
Conor Hale
Jan 13, 2025 10:12am
Illumina rolls out single-flow cell kits for low-volume labs
Jan 9, 2025 12:54pm
Illumina previews updated tumor research assay, ships IVD kits
Nov 22, 2024 9:30am
Illumina updates benchtop sequencer with push-button workflows
Oct 9, 2024 12:10pm
EU court hands Illumina consolation prize over Grail deal
Sep 3, 2024 12:21pm
FDA OKs Illumina's tumor gene test as a companion diagnostic
Aug 28, 2024 12:00pm
